Induction of the Inflammasome by the SARS‐CoV‐2 Accessory Protein ORF9b, Abrogated by Small‐Molecule ORF9b Homodimerization Inhibitors
2025 · Journal of Medical Virology · 4 citations
https://doi.org/10.1002/jmv.70145
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
5
Papers
4
Citations
1
h-index
0
i10-index
Natàlia DeMoya‐Valenzuela is an academic researcher from Hospital Clínico San Carlos. The author has contributed to research in topics: Inflammasome and immune disorders & Kawasaki Disease and Coronary Complications & PARP inhibition in cancer therapy. The author has an h-index of 1, co-authored 5 publications.
ORCID: 0000-0002-7394-7030Click to start Chat